ArticleBMC urology2025
Potential utility of the fatty liver index as a predictor of erectile dysfunction and its severity.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Steatosis indices and penile vascular health: a metabolic association linking liver and vascular phenotypes.Journal of endocrinological investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to evaluate the relationship between Fatty Liver Index(FLI) and Erectile Dysfunction(ED) and its severity. MATERIALS AND
methodsA group of 230 male patients with ED complaints underwent evaluation. Comprehensive routine blood serum tests were conducted to identify potential etiological factors contributing to ED. Additionally, waist circumference(WC) measurements were obtained to facilitate the calculation of the FLI. Participants were also asked to complete the validated Turkish adaptation of the 5-item International Index of Erectile Function (IIEF-5) questionnaire to assess the severity and impact of ED.
resultsOut of all participants, 55 were classified as non-ED, while 175 were diagnosed with ED, mostly in the mild to moderate category. According to FLI scores, 132 had hepatic steatosis(HS). Body mass index (BMI) and WC were significantly higher in the ED group. Fasting blood glucose, ALT, and triglycerides (TG) were elevated in those with ED, while AST and total testosterone levels were lower. A significant association was found between higher FLI scores and ED (p < 0.05). The FLI score was significantly higher (p < 0.05) in the severe ED group compared to the moderate, mild-moderate, and mild ED groups.
conclusionBased on the results of our study, the FLI appears to be a simple method that shows a high correlation with the severity of ED. We believe that the use of the FLI in the diagnosis and follow-up of ED is noteworthy, and further prospective studies with larger sample sizes are needed to support this conclusion.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.